SCHEMBL30280427

SCHEMBL30280427

COc1ccc(-c2cn(S(=O)(=O)c3ccc(C)cc3)c3ncc(B4OC(C)(C)C(C)(C)O4)cc23)cn1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTPN11 Q06124 2/20 0.47
▸ KCNH2 Q12809 4/20 0.38
▸ DGAT1 O75907 1/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ MEN1 O00255 1/20 0.34
▸ USP2 O75604 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ KDR P35968 3/20 0.34
▸ PDGFRB P09619 2/20 0.34
▸ PIM1 P11309 1/20 0.34
▸ PIM2 Q9P1W9 1/20 0.34
▸ CA1 P00915 1/20 0.34
▸ CA2 P00918 1/20 0.34
▸ PTGS1 P23219 1/20 0.34
▸ PTGS2 P35354 1/20 0.34
▸ BRD4 O60885 1/20 0.34
▸ EED O75530 1/20 0.33
▸ TEK Q02763 1/20 0.33
▸ ALPL P05186 1/20 0.33
▸ PIK3CA P42336 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31435950 0.85 PTPN11 (0.47) PTPN11L3MBTL1KDRPDGFRBPIM1
SCHEMBL1516685 0.84 PTPN11 (0.44) PTPN11L3MBTL1MEN1KMT2AKDR
SCHEMBL11968458 0.84 PTPN11 (0.44) PTPN11L3MBTL1KDRPDGFRBBRD4
SCHEMBL1516665 0.83 TSHR (0.44) PTPN11L3MBTL1MEN1KMT2ABRD4
SCHEMBL31436019 0.83 PTPN11 (0.46) PTPN11L3MBTL1KMT2AKDRPDGFRB
SCHEMBL15805493 0.83 PTPN11 (0.44) PTPN11L3MBTL1KDRPDGFRBPIM1
SCHEMBL11968507 0.82 PTPN11 (0.38) PTPN11L3MBTL1PIM1PIM2CA1
SCHEMBL30280360 0.82 PTPN11 (0.51) PTPN11KCNH2L3MBTL1MEN1USP2
SCHEMBL16186654 0.81 PTPN11 (0.37) PTPN11KDRPDGFRBPIM1PIM2
SCHEMBL11968502 0.81 PTPN11 (0.44) PTPN11KCNH2L3MBTL1KDRPDGFRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250019378-A1 PYRROLE[2,3-B]PYRIDINE DERIVATIVES AS TYRO3 INHIBITORS HALIA THERAPEUTICS INC (US) 2025-01-16 — — US disclosed
US-20240425499-A1 TYRO3 INHIBITORS HALIA THERAPEUTICS INC (US) 2024-12-26 — — US disclosed
WO-2023064218-A1 TYRO3 INHIBITORS Halia Therapeutics, Inc. (US) 2023-04-20 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250019378-A1 PYRROLE[2,3-B]PYRIDINE DERIVATIVES AS TYRO3 INHIBITORS TYRO3, TH, TYR PTPN11 65/4885KCNH2 3473/4885DGAT1 4815/4885
US-20240425499-A1 TYRO3 INHIBITORS TYRO3, TYR, TH PTPN11 80/4885KCNH2 2638/4885DGAT1 4577/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback